My interest in botany is mainly limited to the
reproductive processes of vascular plants.
我对植物学的兴趣主要限于维管植物的生殖过程。
Not all doctors fully understand the
reproductive cycle.
并非所有的医生都完全地了解生育周期。
The female
reproductive cells, a female chromosomes, with the X chromosome.
女性生殖细胞只带有雌性染色体，即X染色体。
Liang believes that family welfare policies such as inclusive child care services, equal maternity leave for men and women, protection of the rights of single-parent families, and open access to assisted reproductive technologies, can effectively help working women reduce the time and cost of parenting and achieve a win-win situation for both the family and employers.
梁认为，普惠性育儿服务、男女平等产假、保护单亲家庭权利、开放辅助生殖技术等家庭福利政策，可以有效帮助职场女性减少育儿时间和成本，实现家庭和用人单位双赢。
The company's products, such as whole-genome sequencers, are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
该公司的产品，如全基因组测序仪，用于生命科学、肿瘤学、生殖健康、农业和其他新兴领域的应用。
Ferring Pharmaceuticals, a Swiss multinational biopharmaceutical company specializing in reproductive medicine and maternal health, is to invest more in China, according to a senior executive of the company.
He made the remarks at an exclusive interview with China Daily during a media event held Friday by the Ferring Institute of Reproductive Medicine, a facility founded by the institute and Ferring Pharmaceuticals in 2017 to bring together researchers from both Ferring Pharmaceuticals and the academy to find solutions to address global challenges in fertility and high rates of obstetric complications.
"The institute's long-term collaboration focuses on scientific research in reproductive medicine and maternal health that aims to find new treatments for fertility and pregnancy-related diseases," said Out.
"The Ferring Institute has set up the ISCR-Ferring Reproductive Health Fund to support basic and translational reproductive research in China by integrating resources and collaborating internationally.
To date, the institute has funded 45 projects, covering 23 research units across 11 cities in China, in areas including placenta biology, uterine biology and infertility/pathologies, gametogenesis and male/female infertility and next-generation assisted reproductive technology, as well as its applications.
During the Covid-19 pandemic, the institute also solicited, for the first time, special research projects on the pandemic and reproductive health from Chinese scholars in reproductive biology and reproductive medicine.
In collaboration with The Challenge Initiative, Bayer is providing support for solutions in the area of family planning and reproductive health for women and girls in Africa.
NEW YORK - US reproductive health companies are keen to venture into the "huge and very underserved" Assisted Reproductive Technology (ART) market in China whose infertile population will reach 40 million by 2020.
China presents a unique opportunity for US reproductive health companies as infertility patients in the country are expected to reach 40 million over the next two years, said Dr Kevin Doody, chairman of the Society of Assisted Reproductive Technology (SART), at a recent reception hosted by the Chinese Medical Doctor Association (CMDA) and Global Fertility & Genetics (GFG) Inc in New York City.
Hainan Boao Lecheng International Medical Tourism Pilot Zone, the first of its kind in China, is the best place for the potential collaboration and communication between Chinese and US medical institutions in the field of reproductive health, said Dr Bo Hu, chairman of the CMDA Health Management, and Health Insurance Professional committee, chairman of the Ciming Boao International Hospital.
For example, China's reproductive needs are increasing after the one-child policy was scrapped.
To provide reproductive products and devices for women having difficulties in conceiving, it requires medicine, lab devices, gene analysis, pure lab water and a total solution.
Stocks of reproductive sows, which are still 6 percent higher than normal, will not return to a "reasonable level" until early next year, Chen said.
Women's health and reproductive health suffered massive blows, unintended pregnancies increased, motherhood was delayed, and education disrupted, significantly undermining progress toward gender equality.
As of the beginning of 2020, there were more than 500 medical facilities in China that had been approved to carry out human-assisted reproductive technology.
Currently, most medical institutions that offer reproductive technologies are located in major cities, and experts said some middle-aged couples who would like to have a third child may pursue assisted reproduction technology to maximize the success rate of getting pregnant.
Chinese assisted human reproductive medium suppliers may embrace more business opportunities as domestic demand rises and supply disruptions crimp imports, industry experts said.
Zeng Pinhong, director of the reproductive medical center at the Chongqing Beibu Maternity Hospital, became anxious as imported assisted reproductive medium stocks at the center may not be able to meet the demand.
Assisted reproductive medium has a short shelf-life.
An assisted reproductive medium is helpful in achieving pregnancy as it offers an ideal living environment for sperm, eggs and embryos.
Currently, China sources assisted reproductive medium from other countries.
The National Health Commission said by the end of 2018, there were 498 authorized assisted reproductive institutions in China.
The subcategory in that market of assisted reproductive medium likewise grew at the same time.
Currently, China imports assisted reproductive medium from overseas suppliers such as Vitrolife in Sweden and United States-based CooperSurgical.
The result showed that there was not much difference in indices such as the blastocyst, pregnancy, and implantation rates between domestic and foreign assisted reproductive media.
Industry experts noted that the National Medical Products Administration has strict control over assisted reproductive medium, holding that the birth of life is a sacred and delicate process.
Xiang Xue, a healthcare analyst at Beijing-based think tank Equal-Ocean, said: "The overseas supply shortage may bring opportunities for domestic assisted reproductive medium suppliers.
Like what happened to masks and testing kits, if there is a supply shortage in imported assisted reproductive medium, chances are high that the supervision department would open emergency approval or priority approval channels.
"There are more couples learning about this tech and I think the demand is surging," said Lu Chen, a 29-year-old media professional in Chuzhou, Anhui province, who became father of twins through IVF at the reproductive center at Jiangsu Province Hospital a year ago.
Hu from Bioventure noted that domestic assisted reproductive medium producers are embracing vast opportunities in the market.
"Currently, the NMPA is already actively referring to international experience and opinions from the industry, to adjust its supervision mechanism to support the localization of assisted reproductive medium.
With the introduction of domestic assisted reproductive media, the market value in the sector will be further released," Xiang said.
On Friday United Family Healthcare, a leading private healthcare provider, released the paper, which was mainly based on a survey covering 11,000 Chinese women of reproductive age nationwide.
Endometriosis is a clinical condition affecting approximately 10 percent of women in reproductive age, many of whom experience severe chronic pain with debilitating effects on their professional, personal and social lives.
Top medical experts and scientists from around the world shared with the public the latest cutting-edge research results in medical field such as the coronavirus, infectious diseases, cancer, depression, and reproductive medicine during the 2020 Tencent Medical Enlightenment Summit.
In July of last year, the administration released a guideline with other government departments that require including flexible workers in local maternity insurance programs and exploring subsidizing labor pain relief and assisted reproductive services.